News Conference News ACC 2014 TAVR With the CoreValve Device Superior to Surgery at 1 Year Yael L. Maxwell March 29, 2014
News Conference News ACC 2014 Depth, Cusp Stretching Linked to Need for Pacemaker after TAVR L.A. McKeown March 29, 2014
News Conference News Cell Therapy 2014 Repeat Cell Therapy for Chronic Heart Failure Being Tested in Randomized Trials January 26, 2014
News Conference News AHA 2013 AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice November 24, 2013
News Conference News AHA 2013 French Registry: FFR Safely Reclassifies Almost Half of Revascularization Patients Yael L. Maxwell November 20, 2013
News Conference News AHA 2013 Endovascular Revascularization Benefits PAD Patients When Added to Exercise Therapy Yael L. Maxwell November 18, 2013
News Conference News AHA 2013 Renal Stenting Fails to Improve Outcomes vs. Medical Therapy Alone in RAS Patients Jason Kahn November 17, 2013
News Conference News AHA 2013 Varying Cell Therapy Techniques Demonstrate Safety, Mixed Efficacy at AHA 2013 November 17, 2013
News Conference News TCT 2013 High-Dose Statins before PCI Improved Outcomes in NSTE-ACS November 06, 2013
News Conference News TCT 2013 Pulmonary Artery Denervation Procedure May Improve Hemodynamic Outcomes in PAH November 05, 2013
News Conference News TCT 2013 Studies Find Differing Benefits of Platelet, Genotype Testing October 31, 2013
News Conference News TCT 2013 Regulatory Hurdles Pose Challenges for Device Approvals in US, Europe October 30, 2013
News Conference News TCT 2013 Futuristic 3D Holography May Revolutionize Cardiac Procedures October 30, 2013
News Conference News TCT 2013 Preliminary Data Show Potential of Renal Denervation in Several Settings October 28, 2013
News Conference News ESC 2013 ESC Congress 2013: Mix of Trials with Potential to Reshape Practice September 09, 2013
News Conference News ESC 2013 AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction Caitlin E. Cox September 04, 2013
News Conference News ESC 2013 PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk Yael L. Maxwell September 04, 2013